Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study

被引：0
|
作者：
Makoto Sakai
Makoto Sohda
Hideyuki Saito
Kengo Kuriyama
Tomonori Yoshida
Yuji Kumakura
Keigo Hara
Takehiko Yokobori
Tatsuya Miyazaki
Kazutoshi Murata
Shin-ei Noda
Takashi Nakano
Hiroyuki Kuwano
Ken Shirabe
机构：
[1] Gunma University,Department of General Surgical Science, Graduate School of Medicine
[2] Gunma University Graduate School of Medicine,Department of Innovative Cancer Immunotherapy
[3] Gunma University Graduate School of Medicine,Department of Radiation Oncology
[4] International Medical Center,Department of Radiation Oncology
[5] Saitama Medical University,undefined
[6] Fukuoka City Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Cervical esophageal cancer; Chemoradiotherapy; DCF; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1121 / 1126
页数：5
相关论文
共 50 条
  • [41] EVALUATION OF DOCETAXEL AND 5-FLUOROURACIL WITH CONCURRENT RADIOTHERAPY IN PATIENTS WITH ESOPHAGEAL CANCER
    Atsuta, T.
    Kodani, K.
    Michimoto, K.
    Shimatani, Y.
    Kobayashi, M.
    Ogawa, T.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S225 - S225
  • [42] Phase I study of gemcitabine in combination with cisplatin, 5-fluorouracil and folinic acid in patients with advanced esophageal cancer
    Oettle, H
    Arnold, D
    Kern, M
    Hoepffner, N
    Settmacher, U
    Neuhaus, P
    Riess, H
    ANTI-CANCER DRUGS, 2002, 13 (08) : 833 - 838
  • [43] Docetaxel and Cisplatin Plus Fluorouracil Compared With Modified Docetaxel, Cisplatin, and 5-Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Retrospective Analysis of Single Institution
    Inal, A.
    Kaplan, M. A.
    Kucukoner, M.
    Isikdogan, A.
    NEOPLASMA, 2012, 59 (02) : 233 - 236
  • [44] Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil: a retrospective study
    Fujita, Y.
    Hiramatsu, M.
    Kawai, M.
    Sumiyoshi, K.
    Nishimura, H.
    Tanigawa, N.
    DISEASES OF THE ESOPHAGUS, 2008, 21 (06): : 496 - 501
  • [45] Adverse Prognostic Factors of Advanced Esophageal Cancer in Patients Undergoing Induction Therapy with Docetaxel, Cisplatin and 5-Fluorouracil
    Nakajima, Masanobu
    Muroi, Hiroto
    Kikuchi, Maiko
    Takahashi, Masakazu
    Ihara, Keisuke
    Shida, Yosuke
    Kurayama, Eigo
    Ogata, Hideo
    Yamaguchi, Satoru
    Sasaki, Kinro
    Sakai, Makoto
    Sohda, Makoto
    Miyazaki, Tatsuya
    Kuwano, Hiroyuki
    Kato, Hiroyuki
    ANTICANCER RESEARCH, 2018, 38 (02) : 911 - 918
  • [46] Effectiveness of Combination Chemotherapy With Docetaxel, Nedaplatin, and 5-Fluorouracil for Advanced and Recurrent Esophageal Cancer
    Sohda, Makoto
    Hara, Keigo
    Kuriyama, Kengo
    Tateno, Kouhei
    Uchida, Shintaro
    Watanabe, Takayoshi
    Shibasaki, Yuta
    Saito, Hideyuki
    Nakazawa, Nobuhiro
    Sano, Akihiko
    Sakai, Makoto
    Yokobori, Takehiko
    Ogawa, Hiroomi
    Shirabe, Ken
    Saeki, Hiroshi
    ANTICANCER RESEARCH, 2024, 44 (03) : 1309 - 1315
  • [47] Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT) vs. Cisplatin and 5-Fluorouracil (CF-RT) for Patients With Unresectable Locally Advanced Esophageal Cancer in a Real-world Clinical Setting
    Sakai, Makoto
    Sohda, Makoto
    Saito, Hideyuki
    Nakazawa, Nobuhiro
    Ubukata, Yasunari
    Kuriyama, Kengo
    Hara, Keigo
    Sano, Akihiko
    Ogawa, Hiroomi
    Yokobori, Takehiko
    Murata, Kazutoshi
    Noda, Shin-Ei
    Ohno, Tatsuya
    Shirabe, Ken
    Saeki, Hiroshi
    ANTICANCER RESEARCH, 2021, 41 (04) : 2141 - 2145
  • [48] Combination of 5-fluorouracil and radiation in esophageal cancer
    Herskovic, A
    AlSarraf, M
    SEMINARS IN RADIATION ONCOLOGY, 1997, 7 (04) : 283 - 290
  • [49] Preoperative docetaxel, cisplatin, and 5-fluorouracil for resectable esophagogastric junction adenocarcinoma: A retrospective study
    Hirose, Toshiharu
    Yamamoto, Shun
    Oshima, Kotoe
    Hirano, Hidekazu
    Tsuda, Natsuko Okita
    Shoji, Hirokazu
    Iwasa, Satoru
    Honma, Yoshitaka
    Takashima, Atsuo
    Boku, Narikazu
    Oguma, Zyunya
    Ishiyama, Koshiro
    Hiroyuki, Kato Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [50] Risk factors for febrile neutropenia in neoadjuvant docetaxel, cisplatin, and 5-fluorouracil chemotherapy for esophageal cancer
    Hisanaga Nomura
    Ken Hatogai
    Yosuke Maki
    Nobuo Mochizuki
    Masaki Tanaka
    Shinichiro Saito
    Hiroyuki Daiko
    Takashi Kojima
    Toshikatsu Kawasaki
    Supportive Care in Cancer, 2020, 28 : 1849 - 1854
12345